Long-term survival with oral azacitidine for patients with acute myeloid leukemia in first remission after chemotherapy: Updated results from the randomized, placebo-controlled, phase 3 QUAZAR AML-001 trial.

Overview

authors

Döhner, Hartmut

Ravandi, Farhad

Montesinos, Pau

Dombret, Hervé

Selleslag, Dominik

Risueño, Alberto

Menezes, Daniel

Roboz, Gail J

publication date

February 6, 2023

published in

American journal of hematology Journal

Research

keywords

Leukemia, Myeloid, Acute

Identity

Scopus Document Identifier

85147494639

Digital Object Identifier (DOI)

10.1002/ajh.26847

PubMed ID

36655608

Additional Document Info

volume

98

issue

4